Exponent, Inc.
NASDAQ:EXPOConsulting Services
-$0.25 today
- Market cap
- $4.17B
- Beta
- 0.73
- P/E (TTM)
- 25.9
- EPS (TTM)
- $2.19
- Dividend yield
- 2.15%
Volume 0.40M
Average 0.60M
EXPO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Exponent, Inc.NASDAQ: EXPO
EBITDA · Q3 FY2026 · quarter ended Oct 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $41.88M rose 1.8% year over year, ahead of the -0.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 36.4% from the prior quarter. Over 3 fiscal years it compounded at +4.1% a year.
Context
- EBITDA amounted to 27.0% of revenue in FY2025, down 1.1 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $172.82M (+9.8%) for the fiscal year ending Jan 2027, a step up from the +0.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterOct 2026
- $41.88M+36.4% QoQ
- Last fiscal yearJan 2026
- $157.38M+0.2% YoY
- LTMOct 2026
- $154.08M-0.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1.8% | -0.2% | -2.0 pp |
| 1 year | +0.2% | +9.8% | +9.6 pp |
| 3-year CAGR | +4.1% | +10.3% | +6.1 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 157.38M USD
- Year-over-year change
- +0.2%
- 4-year CAGR
- +4.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-02 | 157.38M | +0.2% |
| FY2024 | 2025-01-03 | 157.06M | +8.5% |
| FY2023 | 2023-12-29 | 144.81M | +3.9% |
| FY2022 | 2022-12-30 | 139.31M | +5.3% |
| FY2021 | 2021-12-31 | 132.32M | — |
EBITDA vs competitors
How EXPO compares with its peers on the latest reported figures
- EXPO's LTM Oct 2026 EBITDA of $154.08M is the 9th highest of the 11 companies compared; the peer median is $307.26M.
- Its year-over-year change of -0.3% is the 7th highest of 10, against a peer median of +5.0%.
- EBITDA amounts to 31.7% of revenue for EXPO, versus a peer median of 10.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $864M | +5.0% | +22.8% | 11.0% | |
| LTM Sep 2026 | $734M | +521.8% | — | 4.6% | |
| LTM Sep 2026 | $687.54M | +2.3% | +10.1% | 13.5% | |
| LTM Jun 2026 | $435.64M | +15.4% | +7.7% | 11.1% | |
LGNLegence Corp. Class A Common stock | LTM Sep 2026 | $319.59M | — | +32.5% | 7.3% |
| LTM Jun 2026 | $294.94M | +56.2% | +9.9% | 7.4% | |
| LTM Sep 2026 | $212M | -0.6% | +13.2% | 11.4% | |
| LTM Mar 2026 | $196.12M | -9.5% | +4.3% | 10.8% | |
| LTM Oct 2026 | $154.08M | -0.3% | +4.1% | 31.7% | |
| LTM Apr 2026 | $98.87M | -4.9% | +3.6% | 12.8% | |
| LTM Apr 2026 | $64.86M | +27.2% | +78.3% | 9.5% | |
| Peer median (excluding EXPO) | $307.26M | +5.0% | +10.1% | 10.9% | |
Competitors are the stored peer set for EXPO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Jan 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 466.27M | 513.29M | 536.77M | 558.51M | 582.01M |
| Cost of Revenue | 342.06M | 348.79M | 401M | 416.23M | 436.71M |
| Gross Profit | 124.21M | 164.5M | 135.76M | 142.28M | 145.31M |
| Gross Margin | 26.6% | 32.0% | 25.3% | 25.5% | 25.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 293.33M | 287.9M | 24.44M | 22.73M | 25.52M |
| Operating Expenses | 15.28M | 23.66M | 24.44M | 22.73M | 25.52M |
| Depreciation & Amortization | 6.49M | 7.08M | 8.92M | 9.69M | 10.08M |
| EBITDA | 132.32M | 139.31M | 144.81M | 157.06M | 157.38M |
| EBITDA Margin | 28.4% | 27.1% | 27.0% | 28.1% | 27.0% |
| Operating Income | 108.93M | 140.84M | 111.32M | 119.56M | 119.79M |
| Operating Margin | 23.4% | 27.4% | 20.7% | 21.4% | 20.6% |
| Interest Income | 66K | 2.1M | 7.15M | 10M | 9.31M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 16.91M | (8.61M) | 24.57M | 27.81M | 27.51M |
| Income Before Tax | 125.84M | 132.23M | 135.9M | 147.37M | 147.3M |
| Pre-Tax Margin | 27.0% | 25.8% | 25.3% | 26.4% | 25.3% |
| Income Tax Expense | 24.64M | 29.9M | 35.56M | 38.37M | 41.29M |
| Net Income | 101.2M | 102.33M | 100.34M | 109M | 106.01M |
| Net Margin | 21.7% | 19.9% | 18.7% | 19.5% | 18.2% |
| EPS (Basic) | 1.92 | 1.98 | 1.96 | 2.13 | 2.08 |
| EPS (Diluted) | 1.90 | 1.96 | 1.94 | 2.11 | 2.07 |
| Weighted Avg Shares | 52.61M | 51.73M | 51.15M | 51.13M | 50.9M |
| Weighted Avg Shares (Diluted) | 53.33M | 52.28M | 51.64M | 51.57M | 51.24M |
Exponent, Inc.
NASDAQ:EXPO
Intrinsic Alpha fair value
Locked
Current Price
$87.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.